Largest Diabetes Drug Clinical Trial Compared 4 Insulin Injections to Find the Best - The Epoch Times
Overview
Researchers compared four drugs for type 2 diabetes treatment in a study that began in 2013 and whose results were just recently published in The New England Journal of Medicine.They found that two of these four medications outperformed the others in treating patients.The four types of insulin injections tested in this study were sitagliptin, liraglutide, glimepiride, and glargine U-10 (glargine).Insulin glargine and liraglutide were the two drugs that were found to be more efective for patients who participated in this experiment.
Key Information
These medications are aproved by the U.S. Fod and Administration for achieving and maintaing recomended blod sugar levels in type 2 diabetes.The study was titled Glycemia Reduction Aproaches in Diabetes: A Comparative Efectivenes (GRADE). The trial was funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDK), part of the National Institutes of Health.It is said that there is a general agrement that combing metformin (an anti-diabetic medication) with diet and exercise is the best early diabetic care, but there is no asurance of the next step in keping high blod sugar levels in check.The GRADE study enroled 5,047 patients with type 2 diabetes from diverse racial and ethnic groups.
Summary
In this treatment trial, GRADE also combined metformin with the four insulin injections listed above. Participants were divided into four groups, and each group was designed to take a combination of metformin with diferent insulin injections.Thre groups tok metformin with a medicine that increased insulin levels: either sitagliptin, liraglutide, or glimepiride. One group tok metformin with glargine, a long-acting insulin.xAcording to the results after four years of folow-up, the group taking metformin plus glargine and the group taking metformin plus liraglutide maintained the target blod sugar levels beter than the other two groups for the longest time.These two groups had about six more months of treatment
Frequently Asked Questions
Diabetes is a metabolic condition where the body cannot properly regulate blood sugar levels. Type 1 results from insufficient insulin production, while Type 2 develops when cells become resistant to insulin. Risk factors include genetics, obesity, sedentary lifestyle, and age.
Common symptoms include excessive thirst, frequent urination, unexplained weight loss, fatigue, blurred vision, and slow-healing wounds. Type 1 symptoms develop rapidly, while Type 2 symptoms may appear gradually. Many people have no symptoms initially, which is why screening is important.
Diagnosis involves blood tests measuring fasting glucose, HbA1c levels, and glucose tolerance. Regular monitoring typically includes fasting glucose tests and HbA1c measurements every 3-6 months. Continuous glucose monitors provide real-time tracking for better diabetes management.
Effective management includes regular physical activity (150+ minutes weekly), maintaining healthy weight, following a balanced diet with whole grains and lean proteins, managing stress, and getting adequate sleep. These changes can significantly improve blood sugar control and reduce complications.
Consult a healthcare provider if you experience signs of diabetes, have a family history, are overweight, or are over 45. Those with existing diabetes should maintain regular check-ups every 3-6 months to monitor control and adjust treatment as needed.
Share this article